Spruce Biosciences, Inc. Interest and Other Income
Spruce Biosciences, Inc. (SPRB) reported Interest and Other Income of $765.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-12
- Spruce Biosciences, Inc. interest and other income for the quarter ending 2026-06-30 was $765.00K, a 296.37% increase year-over-year.
- Spruce Biosciences, Inc. interest and other income for the quarter ending 2026-03-31 was $486.00K, a 47.72% increase year-over-year.
- Spruce Biosciences, Inc. interest and other income for the quarter ending 2025-12-31 was -$40.00K, a 107.01% decline year-over-year.
- Spruce Biosciences, Inc. interest and other income for the quarter ending 2025-09-30 was $36.00K, a 95.54% decline year-over-year.
- Spruce Biosciences, Inc. interest and other income for fiscal 2025 was $1.14M, a 66.77% decline from fiscal 2024.
- Spruce Biosciences, Inc. interest and other income for fiscal 2024 was $3.42M, a 24.91% decline from fiscal 2023.
- Spruce Biosciences, Inc. interest and other income for fiscal 2023 was $4.56M, a 199.21% increase from fiscal 2022.
- Spruce Biosciences, Inc. interest and other income for fiscal 2022 was $1.52M, a 1179.83% increase from fiscal 2021.
| Period end | Interest and Other Income 3 month | Interest and Other Income 3 month as first filed | Interest and Other Income 6 month | Interest and Other Income 6 month as first filed | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $765.00K 10-Q · filed 2026-08-12 | $1.25M 10-Q · filed 2026-08-12 | $1.21M derived: sum of 3 quarters · filed 2026-08-12 | $1.25M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $486.00K 10-Q · filed 2026-05-13 | $446.00K derived: sum of 2 quarters · filed 2026-05-13 | $482.00K derived: sum of 3 quarters · filed 2026-05-13 | $675.00K derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$4.00K derived: sum of 2 quarters · filed 2026-03-09 | $189.00K derived: sum of 3 quarters · filed 2026-08-12 | $1.14M 10-K · filed 2026-03-09 | ||
| 2025-09-30 | $36.00K 10-Q · filed 2025-11-10 | $229.00K derived: sum of 2 quarters · filed 2026-08-12 | $1.18M 10-Q · filed 2025-11-10 | $1.13M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $193.00K 10-Q · filed 2026-08-12 | $654.00K 10-Q · filed 2025-08-14 | $522.00K 10-Q · filed 2026-08-12 | $1.14M 10-Q · filed 2025-08-14 | $1.09M derived: sum of 3 quarters · filed 2026-08-12 | $1.90M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $329.00K 10-Q · filed 2026-05-13 | $487.00K 10-Q · filed 2025-05-06 | $900.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.71M derived: sum of 3 quarters · filed 2026-05-13 | $2.65M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $571.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.38M derived: sum of 2 quarters · filed 2026-03-09 | $2.32M derived: sum of 3 quarters · filed 2026-03-09 | $3.42M 10-K · filed 2026-03-09 | ||
| 2024-09-30 | $808.00K 10-Q · filed 2025-11-10 | $1.75M derived: sum of 2 quarters · filed 2025-11-10 | $2.85M 10-Q · filed 2025-11-10 | $4.17M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $938.00K 10-Q · filed 2025-08-14 | $2.04M 10-Q · filed 2025-08-14 | $3.36M derived: sum of 3 quarters · filed 2025-08-14 | $4.79M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-06 | $2.42M derived: sum of 2 quarters · filed 2025-05-06 | $3.85M derived: sum of 3 quarters · filed 2025-05-06 | $5.12M derived: sum of 4 quarters · filed 2025-05-06 | ||
| 2023-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $2.74M derived: sum of 2 quarters · filed 2025-04-15 | $4.02M derived: sum of 3 quarters · filed 2025-04-15 | $4.56M 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $1.42M 10-Q · filed 2023-11-13 | $2.70M derived: sum of 2 quarters · filed 2023-11-13 | $3.24M 10-Q · filed 2023-11-13 | $4.33M derived: sum of 4 quarters · filed 2024-03-18 | ||
| 2023-06-30 | $1.27M 10-Q · filed 2023-08-14 | $1.81M 10-Q · filed 2023-08-14 | $2.91M derived: sum of 3 quarters · filed 2024-03-18 | $3.17M derived: sum of 4 quarters · filed 2024-03-18 | ||
| 2023-03-31 | $539.00K 10-Q · filed 2023-05-15 | $1.63M derived: sum of 2 quarters · filed 2024-03-18 | $1.90M derived: sum of 3 quarters · filed 2024-03-18 | $2.00M derived: sum of 4 quarters · filed 2024-03-18 | ||
| 2022-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $1.36M derived: sum of 2 quarters · filed 2024-03-18 | $1.47M derived: sum of 3 quarters · filed 2024-03-18 | $1.52M 10-K · filed 2024-03-18 | ||
| 2022-09-30 | $266.00K 10-Q · filed 2023-11-13 | $370.00K derived: sum of 2 quarters · filed 2023-11-13 | $428.00K 10-Q · filed 2023-11-13 | $467.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $104.00K 10-Q · filed 2023-08-14 | $162.00K 10-Q · filed 2023-08-14 | $201.00K derived: sum of 3 quarters · filed 2023-08-14 | $242.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $58.00K 10-Q · filed 2023-05-15 | $97.00K derived: sum of 2 quarters · filed 2023-05-15 | $138.00K derived: sum of 3 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $80.00K derived: sum of 2 quarters · filed 2023-03-16 | $119.00K 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $41.00K 10-Q · filed 2022-11-10 | $80.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |